REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial

Depressive Disorder ◽

Adjunctive Treatment ◽

Double Blind Trial ◽

Major Depressive ◽

Double Blind ◽

Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder

Current Medical Research and Opinion ◽

10.1185/030079907x188107 ◽

2007 ◽

Vol 23 (6) ◽

pp. 1303-1318 ◽

Cited By ~ 39

Author(s):

Teresa A. Pigott ◽

Apurva Prakash ◽

Lesley M. Arnold ◽

Scott T. Aaronson ◽

Craig H. Mallinckrodt ◽

...

Keyword(s):

Depressive Disorder ◽

Double Blind Trial ◽

Major Depressive ◽

Double Blind ◽

P.2.b.005 Effects of vilazodone on sexual dysfunction in major depressive disorder: randomised, double-blind trial with placebo and active controls

European Neuropsychopharmacology ◽

10.1016/s0924-977x(14)70607-8 ◽

2014 ◽

Vol 24 ◽

pp. S380-S381

Author(s):

A.H. Clayton ◽

C. Gommoll ◽

D. Chen ◽

R. Nunez ◽

M. Mathews

Keyword(s):

Sexual Dysfunction ◽

Depressive Disorder ◽

Double Blind Trial ◽

Major Depressive ◽

Double Blind ◽

Blind Trial ◽

Active Controls

A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder

Current Medical Research and Opinion ◽

10.1185/03007995.2012.761600 ◽

2013 ◽

Vol 29 (3) ◽

pp. 217-226 ◽

Cited By ~ 70

Author(s):

Atul R. Mahableshwarkar ◽

Paula L. Jacobsen ◽

Yinzhong Chen

Keyword(s):

Depressive Disorder ◽

Double Blind Trial ◽

Major Depressive ◽

Double Blind ◽

An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major Depressive Disorder

The Primary Care Companion For CNS Disorders ◽

10.4088/pcc.14m01734 ◽

2015 ◽

Cited By ~ 2

Author(s):

Shilpa Rele ◽

Robert Millet ◽

Sungman Kim ◽

Jong-Woo Paik ◽

Seonghwan Kim ◽

...

Keyword(s):

Depressive Disorder ◽

Double Blind Trial ◽

Major Depressive ◽

Double Blind ◽

Faculty of 1000 evaluation for Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718026620.793482513 ◽

2013 ◽

Author(s):

Konstantinos Fountoulakis

Keyword(s):

Depressive Disorder ◽

Double Blind Trial ◽

Emotional Experiences ◽

Major Depressive ◽

Double Blind ◽

Subjective Sleep ◽

Blind Trial ◽

Randomized Controlled

Controlled Double-Blind Trial of Phenytoin vs. Fluoxetine in Major Depressive Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.v66n0507 ◽

2005 ◽

Vol 66 (05) ◽

pp. 586-590 ◽

Cited By ~ 18

Author(s):

Boris Nemets ◽

Yuly Bersudsky ◽

R. H. Belmaker

Keyword(s):

Depressive Disorder ◽

Double Blind Trial ◽

Major Depressive ◽

Double Blind ◽

A double-blind, placebo-controlled study of edivoxetine as an adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment

Journal of Affective Disorders ◽

10.1016/j.jad.2014.06.006 ◽

2014 ◽

Vol 167 ◽

pp. 215-223 ◽

Cited By ~ 9

Author(s):

Susan Ball ◽

Mary Anne Dellva ◽

Deborah N. D'Souza ◽

Lauren B. Marangell ◽

James M. Russell ◽

...

Keyword(s):

Depressive Disorder ◽

Selective Serotonin Reuptake Inhibitor ◽

Serotonin Reuptake ◽

Adjunctive Treatment ◽

Controlled Study ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Inhibitor Treatment

Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study

Journal of Psychiatric Research ◽

10.1016/j.jpsychires.2020.05.017 ◽

2020 ◽

Vol 128 ◽

pp. 43-51

Author(s):

Makoto Kamiya ◽

Helene D. Sabia ◽

Julie Marella ◽

Maurizio Fava ◽

Charles B. Nemeroff ◽

...

Keyword(s):

Depressive Disorder ◽

Receptor Antagonist ◽

Adjunctive Treatment ◽

Controlled Study ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

V1b Receptor

N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials

Psychopharmacology ◽

10.1007/s00213-020-05629-2 ◽

2020 ◽

Vol 237 (11) ◽

pp. 3481-3487 ◽

Cited By ~ 1

Author(s):

Taro Kishi ◽

Nobumi Miyake ◽

Makoto Okuya ◽

Kenji Sakuma ◽

Nakao Iwata

Keyword(s):

Systematic Review ◽

Depressive Disorder ◽

Bipolar Depression ◽

Meta Analysis ◽

Adjunctive Treatment ◽

Controlled Trials ◽

Major Depressive ◽

Double Blind

Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial

Clinical Psychopharmacology and Neuroscience ◽

10.9758/cpn.2014.12.3.180 ◽

2014 ◽

Vol 12 (3) ◽

pp. 180-188 ◽

Cited By ~ 29

Author(s):

Olivia May Dean ◽

Michael Maes ◽

Melanie Ashton ◽

Lesley Berk ◽

Buranee Kanchanatawan ◽

...

Keyword(s):

Depressive Disorder ◽

Controlled Trial ◽

Adjunctive Treatment ◽

Major Depressive ◽

Double Blind